Your browser doesn't support javascript.
loading
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Michalak, Ewa M; Visvader, Jane E.
Affiliation
  • Michalak EM; ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: michalak@wehi.edu.au.
  • Visvader JE; ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: visvader@wehi.edu.au.
Mol Oncol ; 10(10): 1497-1515, 2016 12.
Article in En | MEDLINE | ID: mdl-27717710

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Arginine N-Methyltransferases / Breast / Breast Neoplasms / Gene Expression Regulation, Neoplastic / Histone-Lysine N-Methyltransferase Limits: Animals / Female / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Arginine N-Methyltransferases / Breast / Breast Neoplasms / Gene Expression Regulation, Neoplastic / Histone-Lysine N-Methyltransferase Limits: Animals / Female / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States